Would you enjoy leading drug development for rare conditions? Are you a medic with experience designing clinical trials and interacting with regulatory authorities?
If so, now is your chance to join Ascendis Pharma as our new Medical Director, Clinical Development, Endocrine & Rare Diseases
Ascendis Pharma is a global biopharmaceutical company committed to making a meaningful difference in patients’ lives. Guided by our core values of Patients, Science, and Passion, we are applying our innovative TransCon® technology platform to fulfill our mission of developing new therapies that demonstrate best-in-class potential to address unmet medical needs.
At our headquarters in Hellerup, Denmark, research facilities in Heidelberg, Germany, and additional offices across Europe and the United States, we are advancing programs in our Endocrinology Rare Disease and Oncology portfolios. We also collaborate with partners on the development of TransCon-based products in other therapeutic areas and markets.
We are seeking an energetic Medical Director to join our growing team. As a key member of the Ascendis Pharma team, you will play a crucial role in driving the design, safety monitoring, and data analysis of the Company’s late-phase clinical trials studying TransCon C-type natriuretic peptide (CNP). This is an exciting opportunity to work in a fast-paced environment, collaborate with cross-functional, global teams working together to achieve extraordinary results.
You will report directly to the VP, Clinical Science, Endocrine and Rare Disease Medical Sciences.
Your key responsibilities will be
Qualifications and Skills:
Key competencies:
You have excellent communication skills, both written and verbal, and you learn quickly, even when working under pressure. You’re able to follow complex instructions, multitask effectively, and still maintain a strong attention to detail. You lead confidently — both through your actions and when guiding others — and you’re known for being a trustworthy, collaborative team player. You take initiative, solve complex problems with ease, and demonstrate sound judgment, especially when handling confidential, sensitive, or regulated information
Travel: Up to 20%.
Office: Ascendis Pharma Headquarters, Tuborg Boulevard 12, 2900 Hellerup, Denmark
Apply now.
Applications will be evaluated when received, so please apply as soon as possible.
All applications must be submitted in English and are treated confidentially.
A note to recruiters:
We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma HR team (specifically from: Talent Acquisition Partner or Human Resources Director) is not allowed. If this occurs, your ownership of these candidates will not be acknowledged.
Founded in Copenhagen, Denmark in 2007, Ascendis Pharma is a publicly held, biopharmaceutical company committed to addressing unmet medical needs. Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon™ technologies to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three independent endocrinology rare disease product candidates in clinical development and established advancing oncology as its second therapeutic area of focus. The company continues to expand into additional therapeutic areas to address unmet patient needs. Ascendis is headquartered in Copenhagen, Denmark, with offices in Heidelberg, Germany, Princeton, New Jersey, and Palo Alto, California.
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!
Be the first to apply. Receive an email whenever similar jobs are posted.
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Medical Director Q&A's